Clinical Trial Update: A Study of LX107 Gene Therapy in AIPL1-IRD Patients [EARLY_Phase 1]

View source ↗

Summary

A first-in-human early-phase clinical trial evaluating LX107 gene therapy for AIPL1-related inherited retinal dystrophy is currently recruiting in China. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Retinal Dystrophy

Drugs mentioned

• LX107 (LX107)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Retinal Dystrophy | EARLY_Phase 1 | Status: RECRUITING